[HTML][HTML] The new research ethic: will oversight requirements sink forensic research?

PJ Candilis, R Arikan, SB Noone… - The journal of the …, 2005 - ncbi.nlm.nih.gov
The conduct of research with human participants is facing increased scrutiny from
government, media, and academic sources. Research oversight is consequently increasing …

The Orexin-1 antagonist SB-334867 blocks antipsychotic treatment–emergent catalepsy: implications for the treatment of extrapyramidal symptoms

K Rasmussen, MA Hsu, S Noone… - Schizophrenia …, 2007 - academic.oup.com
We have previously shown that the orexin-1 antagonist SB-334867 blocks the electrophysiological
effects of haloperidol and olanzapine on the activity of A9 and A10 dopamine neurons…

[BOOK][B] Treading on thin ice: A qualitative study of women and HIV disclosure

SB Noone - 2000 - search.proquest.com
… Almost 13% of the sample had disclosed to no one and 30% had disclosed to only one
person” (p. 475). Of interest, the younger participants were most likely to disclose; English-…

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

…, J Drijkoningen, P Gilligan, CR Esther, PG Noone… - Science, 2016 - science.org
Lung infections with Mycobacterium abscessus, a species of multidrug-resistant nontuberculous
mycobacteria, are emerging as an important global threat to individuals with cystic …

The nature of the response in discrimination learning.

KW Spence - Psychological review, 1952 - psycnet.apa.org
… It represents a situation in which no one of the cue elements SWj SBSB), so that eventually
response is always made to the stimulus complex (alley, window, etc.) that contains it, no one

Heliostat field optimization: A new computationally efficient model and biomimetic layout

CJ Noone, M Torrilhon, A Mitsos - Solar Energy, 2012 - Elsevier
In this article, a new model and a biomimetic pattern for heliostat field layout optimization are
introduced. The model, described and validated herein, includes a detailed calculation of …

[HTML][HTML] Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

…, F Seillier-Moiseiwitsch, AM Noone… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
Purpose Five or more circulating tumor cells (CTCs) per 7.5 mL of blood predicts for poorer
progression-free survival (PFS) in patients with metastatic breast cancer (MBC). We …

The Various Sources of Venture Capital Available to Small Business Concerns

CM Noone - The Business Lawyer, 1971 - JSTOR
… of $618 million including some $217 million borrowed from SB It was the availability of these
… Of their total outstanding financings at September 30, 1969, SB had approximately $280 …

[HTML][HTML] Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians

…, KL Taylor, AB Kornblith, AM Noone… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Breast cancer chemotherapy decisions in patients≥ 65 years old (older) are complex
because of comorbidity, toxicity, and limited data on patient preference. We examined …

[CITATION][C] P1‐174: Dementia Screening in Low Education Populations: Results from the Kerala‐Einstein Study

J Verghese, A Ambrose, M Noone… - Alzheimer's & …, 2011 - Wiley Online Library
… This association was not significant when looking at 2-year CDR-SB change score. In NC …
-SB and NPI-Q items. However, there was a significant association between 3-year CDR-SB